IBDEI1LX ; ; 01-FEB-2022
 ;;3.0;IB ENCOUNTER FORM IMP/EXP;;FEB 01, 2022
 Q:'DIFQR(358.4)  F I=1:2 S X=$T(Q+I) Q:X=""  S Y=$E($T(Q+I+1),4,999),X=$E(X,4,999) S:$A(Y)=126 I=I+1,Y=$E(Y,2,999)_$E($T(Q+I+1),5,999) S:$A(Y)=61 Y=$E(Y,2,999) X NO E  S @X=Y
Q Q
 ;;^UTILITY(U,$J,358.4,62,0)
 ;;=BREASTS and GYN NEOPLASMS^3^9
 ;;^UTILITY(U,$J,358.4,63,0)
 ;;=COAGULATION DISORDERS^4^9
 ;;^UTILITY(U,$J,358.4,64,0)
 ;;=COUNSELING AND SCREENING^5^9
 ;;^UTILITY(U,$J,358.4,65,0)
 ;;=GENITOURINARY NEOPLASMS^6^9
 ;;^UTILITY(U,$J,358.4,66,0)
 ;;=GI CANCER^7^9
 ;;^UTILITY(U,$J,358.4,67,0)
 ;;=HEAD NECK AND LUNGS NEOPLASMS^8^9
 ;;^UTILITY(U,$J,358.4,68,0)
 ;;=HEMOGLOBINOPATHIES^9^9
 ;;^UTILITY(U,$J,358.4,69,0)
 ;;=LYMPHOID NEOPLASMS^10^9
 ;;^UTILITY(U,$J,358.4,70,0)
 ;;=METASTATIC SITES^13^9
 ;;^UTILITY(U,$J,358.4,71,0)
 ;;=MALIGNANT NEOPLASMS OF OTHER SITES^11^9
 ;;^UTILITY(U,$J,358.4,72,0)
 ;;=MYELOID NEOPLASMS AND DISORDERS^14^9
 ;;^UTILITY(U,$J,358.4,73,0)
 ;;=NEOPLASM OF UNCERTAIN BEHAVIOR^15^9
 ;;^UTILITY(U,$J,358.4,74,0)
 ;;=NEOPLASM OF UNSPECIFIED NATURE^16^9
 ;;^UTILITY(U,$J,358.4,75,0)
 ;;=PERSONAL HISTORY^19^9
 ;;^UTILITY(U,$J,358.4,76,0)
 ;;=MALNUTRITION^12^9
 ;;^UTILITY(U,$J,358.4,77,0)
 ;;=OTHER^18^9
 ;;^UTILITY(U,$J,358.4,78,0)
 ;;=SUICIDE IDEATIONS/ATTEMPTS^20^9
 ;;^UTILITY(U,$J,358.4,79,0)
 ;;=ACOUSTIC NERVE INJURIES^1^10
 ;;^UTILITY(U,$J,358.4,80,0)
 ;;=AUDITORY DISORDERS^2^10
 ;;^UTILITY(U,$J,358.4,81,0)
 ;;=BALANCE DISORDERS^3^10
 ;;^UTILITY(U,$J,358.4,82,0)
 ;;=BAROTRAUMA^4^10
 ;;^UTILITY(U,$J,358.4,83,0)
 ;;=EAR DISEASE^5^10
 ;;^UTILITY(U,$J,358.4,84,0)
 ;;=FOREIGN BODIES^7^10
 ;;^UTILITY(U,$J,358.4,85,0)
 ;;=HEARING LOSS^8^10
 ;;^UTILITY(U,$J,358.4,86,0)
 ;;=NOISE INJURIES^9^10
 ;;^UTILITY(U,$J,358.4,87,0)
 ;;=NYSTAGMUS^10^10
 ;;^UTILITY(U,$J,358.4,88,0)
 ;;=OTOTOXICITY^11^10
 ;;^UTILITY(U,$J,358.4,89,0)
 ;;=PURPOSE OF ENCOUNTER/HEALTH STATUS^12^10
 ;;^UTILITY(U,$J,358.4,90,0)
 ;;=EXTERNAL EAR DISEASES^6^10
 ;;^UTILITY(U,$J,358.4,91,0)
 ;;=NEW PATIENT^2^11
 ;;^UTILITY(U,$J,358.4,92,0)
 ;;=ESTABLISHED PATIENT^1^11
 ;;^UTILITY(U,$J,358.4,93,0)
 ;;=CONSULTATIONS^3^11
 ;;^UTILITY(U,$J,358.4,94,0)
 ;;=AUDIOLOGIC FUNCTION TESTS^1^12
 ;;^UTILITY(U,$J,358.4,95,0)
 ;;=SCREENING^12^12
 ;;^UTILITY(U,$J,358.4,96,0)
 ;;=COCHLEAR IMPLANT^2^12
 ;;^UTILITY(U,$J,358.4,97,0)
 ;;=OTHER TREATMENT^9^12
 ;;^UTILITY(U,$J,358.4,98,0)
 ;;=DISPENSING^4^12
 ;;^UTILITY(U,$J,358.4,99,0)
 ;;=REMOVAL FOREIGN BODY/CERUMEN^11^12
 ;;^UTILITY(U,$J,358.4,100,0)
 ;;=VESTIBULAR FUNCT W/ RECORDING^14^12
 ;;^UTILITY(U,$J,358.4,101,0)
 ;;=VESTIBULAR FUNCT W/O RECORDING^15^12
 ;;^UTILITY(U,$J,358.4,102,0)
 ;;=EVALUATIVE & THERAPEUTIC SVCS^5^12
 ;;^UTILITY(U,$J,358.4,103,0)
 ;;=TEAM CONFERENCE^13^12
 ;;^UTILITY(U,$J,358.4,104,0)
 ;;=PROLONGED CLINICAL STAFF SERVICES^10^12
 ;;^UTILITY(U,$J,358.4,105,0)
 ;;=OTHER SERVICES^8^12
 ;;^UTILITY(U,$J,358.4,106,0)
 ;;=DEVICES & EQUIPMENT^3^12
 ;;^UTILITY(U,$J,358.4,107,0)
 ;;=EXCISION^6^12
 ;;^UTILITY(U,$J,358.4,108,0)
 ;;=INCISION^7^12
 ;;^UTILITY(U,$J,358.4,109,0)
 ;;=NEW PATIENT^2^13
 ;;^UTILITY(U,$J,358.4,110,0)
 ;;=ESTABLISHED PATIENT^1^13
 ;;^UTILITY(U,$J,358.4,111,0)
 ;;=CONSULTATIONS^3^13
 ;;^UTILITY(U,$J,358.4,112,0)
 ;;=ARRHYTHMIA^3^14
 ;;^UTILITY(U,$J,358.4,113,0)
 ;;=CHEST PAIN^4^14
 ;;^UTILITY(U,$J,358.4,114,0)
 ;;=CHF/MYOPATHY/TRANSPLANT^5^14
 ;;^UTILITY(U,$J,358.4,115,0)
 ;;=CORONARY ATHEROSCLEROSIS^6^14
 ;;^UTILITY(U,$J,358.4,116,0)
 ;;=GENERAL SYMPTOMS^9^14
 ;;^UTILITY(U,$J,358.4,117,0)
 ;;=HISTORY^12^14
 ;;^UTILITY(U,$J,358.4,118,0)
 ;;=HYPERTENSION/HYPOTENSION^13^14
 ;;^UTILITY(U,$J,358.4,119,0)
 ;;=INFECTION/INFLM DISEASE^14^14
 ;;^UTILITY(U,$J,358.4,120,0)
 ;;=LIPID DISORDER^15^14
